Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| MODERNA | 2 | 16 | -9,19 % | ||
| BIONTECH | 1 | 13 | +3,14 % | ||
| COMPASS PATHWAYS | 1 | 11 | 0,00 % | ||
| LEXEO THERAPEUTICS | 1 | 3 | -3,03 % | ||
| ANAVEX LIFE SCIENCES | 1 | - | -3,56 % | ||
| MIND MEDICINE | 1 | - | +4,69 % | ||
| 4D MOLECULAR THERAPEUTICS | 1 | - | -1,54 % | ||
| JANUX THERAPEUTICS | 1 | - | -0,42 % | ||
| ATAI BECKLEY | 1 | - | +12,62 % | ||
| ABSCI | 1 | - | +0,28 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08:58 | Jefferies bestätigt Kaufempfehlung für Sanofi-Aktie mit Kursziel von 100 Euro | 2 | Investing.com Deutsch | ||
| 08:54 | Jefferies reiterates Buy rating on Sanofi stock, maintains EUR100 price target | 3 | Investing.com | ||
| Sa | Forget Moderna Stock, This is a Much Better Buy | 29 | The Motley Fool | ||
| Sa | Why COMPASS Pathways plc (CMPS) Draws Both Optimism and Caution | 3 | Insider Monkey | ||
| Sa | Why Everyone Is Watching 4D Molecular Therapeutics, Inc. (FDMT) Closely | 3 | Insider Monkey | ||
| Sa | Why Wall Street Sees Big Potential in Janux Therapeutics, Inc. (JANX) | 4 | Insider Monkey | ||
| Sa | JonesTrading Highlights Differentiated Pipeline at Atai Beckley N.V. (ATAI) | 14 | Insider Monkey | ||
| Sa | Absci Corporation (ABSI) Draws Full Buy Consensus With 150% Upside Potential | 1 | Insider Monkey | ||
| Sa | What's Driving JonesTrading's Bullish View on Mind Medicine (MindMed) Inc. (MNMD) | 1 | Insider Monkey | ||
| Sa | Wall Street Rallies Behind Lexeo Therapeutics (LXEO)'s Gene Therapy Pipeline | 2 | Insider Monkey | ||
| Sa | MODERNA INC bricht ein - Panik greift um sich! | 14 | Maximilian Berger | ||
| Sa | Medizinisches Cannabis war gestern? Bioxyne, ATAI und MindMed positionieren sich mit MDMA im wachsenden Markt für psychedelische Therapien | Small- & Micro Cap Investment | |||
| Sa | Cathie Wood: ARK Invest stockt bei CRISPR Therapeutics deutlich auf | 29 | Investing.com Deutsch | ||
| Fr | Omeros scores its first-ever FDA nod as stem cell transplant drug Yartemlea approved | 6 | FiercePharma | ||
| Fr | Hedge Fund and Insider Trading News: Ken Griffin, Ray Dalio, Warren Buffett, Toms Capital, Ken Fisher, Pershing Square, Amylyx Pharmaceuticals Inc (AMLX), NVIDIA Corp (NVDA), and More | 16 | Insider Monkey | ||
| Fr | Collegium Pharmaceutical: Aktie markiert Rekordhoch bei 49,92 USD | 1 | Investing.com Deutsch | ||
| Fr | Vanda Pharmaceuticals Stock Rallies on FDA Filing | 15 | Schaeffer's Research | ||
| Fr | Stifel reiterates Buy rating on Xenon Pharmaceuticals stock amid competitor setback | 3 | Investing.com | ||
| Fr | Weekly Buzz: FDA OKs Roche's Lunsumio VELO; It's No For Tolbrutinib; BioMarin, Sanofi Open Wallets | 624 | AFX News | SOUTH SAN FRANCISCO (dpa-AFX) - In a holiday-shortened week, the biotech sector saw a wave of FDA approvals, strategic acquisitions, and key clinical trial readouts - alongside several setbacks... ► Artikel lesen | |
| Fr | Why Did Edgewise Therapeutics Jump 25%+ On Wednesday? | 1 | Forbes |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .